Three SROs of the DRAP provide details of 898, 67 and 128 kinds of medicines that included brand names, compositions, names of manufacturing companies, sizes of packing and maximum retail prices of syrups, tablets, capsules and various injections.
The SROs directed companies that the prices fixed by DRAP should be printed on the packing.
The statement said that the new prices would not be applicable on the medicines which were registered before the issuance of the notification while it would be mandatory for the manufacturers and importers of the medicines to present the RMP to the costing and pricing division of DRAP.